Mednax Company Insiders
| MD Stock | USD 21.90 0.61 2.87% |
Mednax employs about 4.1 K people. The company is managed by 48 executives with a total tenure of roughly 262 years, averaging almost 5.0 years of service per executive, having 85.83 employees per reported executive. Evaluation of Mednax's management performance can provide insight into the firm performance.
| Roger Medel CEO Chief Executive Officer, Director |
| Cesar Alvarez Chairman Independent Chairman of the Board |
Mednax Management Team Effectiveness
The company has Return on Asset (ROA) of 0.0686 % which means that for every $100 of assets, it generated a profit of $0.0686. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.1998 %, which means that it produced $0.1998 on every 100 dollars invested by current stockholders. Mednax's management efficiency ratios could be used to measure how well Mednax manages its routine affairs as well as how well it operates its assets and liabilities.Mednax Inc maintains a total of 85.88 Million outstanding shares. The majority of Mednax outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Mednax Inc to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Mednax Inc. Please pay attention to any change in the institutional holdings of Mednax as this could imply that something significant has changed or is about to change at the company. Also note that almost eight hundred fifty thousand one hundred eighty-six invesors are currently shorting Mednax expressing very little confidence in its future performance.
Some institutional investors establish a significant position in stocks such as Mednax in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Mednax, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Mednax Workforce Comparison
Mednax Inc is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 150,435. Mednax holds roughly 4,120 in number of employees claiming about 2.74% of equities under Health Care industry.
The company has Net Profit Margin (PM) of 0.08 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.15 %, which signifies that for every $100 of sales, it has a net operating income of $0.15. Mednax Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mednax insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mednax's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Mednax insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Pickert Curtis over a month ago Disposition of 751 shares by Pickert Curtis of Mednax at 7.31 subject to Rule 16b-3 | ||
Linynsky Laura A over a month ago Disposition of 10000 shares by Linynsky Laura A of Mednax at 21.65 subject to Rule 16b-3 | ||
Lee Wood over three months ago Disposition of 407 shares by Lee Wood of Mednax at 13.3 subject to Rule 16b-3 | ||
Thomas McEachin over three months ago Disposition of 625 shares by Thomas McEachin of Mednax subject to Rule 16b-3 | ||
Thomas McEachin over three months ago Disposition of 54021 shares by Thomas McEachin of Mednax subject to Rule 16b-3 | ||
Newman Kurt Douglas over three months ago Acquisition by Newman Kurt Douglas of 9737 shares of Mednax subject to Rule 16b-3 | ||
Mary Moore over six months ago Disposition of 10371 shares by Mary Moore of Mednax subject to Rule 16b-3 | ||
Mary Moore over six months ago Disposition of 6729 shares by Mary Moore of Mednax at 14.15 subject to Rule 16b-3 |
Mednax Notable Stakeholders
A Mednax stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Mednax often face trade-offs trying to please all of them. Mednax's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Mednax's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| James MD | CEO Director | Profile | |
| Roger Medel | Chief Executive Officer, Director | Profile | |
| Mark Ordan | Chief Executive Officer, Director | Profile | |
| Cesar Alvarez | Independent Chairman of the Board | Profile | |
| Dominic Andreano | Executive Vice President, General Counsel, Secretary | Profile | |
| C Richards | Chief Financial Officer, Executive Vice President, Principal Accounting Officer | Profile | |
| Kevin Pitzer | President Division | Profile | |
| Linda Chen | President Operations | Profile | |
| Stephen Farber | Chief Financial Officer, Executive Vice President | Profile | |
| Michael MD | President Operations | Profile | |
| John Pepia | Senior Vice President, Chief Accounting Officer | Profile | |
| Mike Ashford | President Operations | Profile | |
| Suzanne Heck | President Market | Profile | |
| Debra Kaspar | President Market | Profile | |
| Marc Richards | Executive CFO | Profile | |
| Curtis MD | Executive COO | Profile | |
| Enrique Sosa | Independent Director | Profile | |
| Paul Gabos | Independent Director | Profile | |
| Pascal Goldschmidt | Independent Director | Profile | |
| Waldemar Carlo | Independent Director | Profile | |
| Manuel Kadre | Lead Independent Director | Profile | |
| Michael Fernandez | Independent Director | Profile | |
| Karey Barker | Independent Director | Profile | |
| Kasandra Rossi | Treasurer VP | Profile | |
| Charles CFA | Strategy Finance | Profile | |
| Nanette Sanders | Executive Operations | Profile | |
| Debra McRoberts | Senior Services | Profile | |
| Nikos Nikolopoulos | Executive Vice President Chief Strategy and Growth Officer | Profile | |
| Michael Rucker | Independent Director | Profile | |
| Mary Moore | Executive Vice President Chief Enterprise Risk and Legal Operations Officer | Profile | |
| Carlos Migoya | Independent Director | Profile | |
| Jonathan Griffin | Integration Growth | Profile | |
| John Starcher | Independent Director | Profile | |
| Shirley Weis | Independent Director | Profile | |
| Gregory Neeb | Executive Officer | Profile | |
| Michael Lima | Senior Finance | Profile | |
| CPC MBA | Senior Services | Profile | |
| Roger Hinson | President Pediatrix and Obstetrix Medical Group | Profile | |
| Meghan Lublin | Chief VP | Profile | |
| Dana DreherRodwell | VP Officer | Profile | |
| Guy Sansone | Independent Chairman of the Board | Profile | |
| Lee Wood | Executive Operations | Profile | |
| Roger MD | CoFounder Director | Profile | |
| Cheryl VanPatten | Senior Officer | Profile | |
| Mary JD | Executive Officer | Profile | |
| Thomas McEachin | Independent Director | Profile | |
| Cheryl VanPattan | VP Officer | Profile | |
| Daniel Corcoran | Senior Care | Profile |
About Mednax Management Performance
The success or failure of an entity such as Mednax Inc often depends on how effective the management is. Mednax management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Mednax management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Mednax management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida. Pediatrix Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 5000 people.
Please note, the presentation of Mednax's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mednax's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Mednax's management manipulating its earnings.
Mednax Workforce Analysis
Traditionally, organizations such as Mednax use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Mednax within its industry.Mednax Manpower Efficiency
Return on Mednax Manpower
| Revenue Per Employee | 488.6K | |
| Revenue Per Executive | 41.9M | |
| Net Loss Per Employee | 24K | |
| Net Loss Per Executive | 2.1M | |
| Working Capital Per Employee | 49.9K | |
| Working Capital Per Executive | 4.3M |
Complementary Tools for Mednax Stock analysis
When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |